KYLE LEFEVRE: Open Payments
NPI 1982315958 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,524 in 76 payments from 20 companies in 2025. Trend: 2023 $1,384 · 2024 $1,648 · 2025 $2,524
Food & beverage: $2,203Education: $321
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $530 |
| Astellas Pharma US Inc | 5 | $268 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $225 |
| UROGEN PHARMA, INC. | 7 | $211 |
| Sumitomo Pharma America, Inc. | 8 | $178 |
| Dendreon Pharmaceuticals LLC | 3 | $169 |
| Telix Pharmaceuticals | 7 | $158 |
| Boston Scientific Corporation | 4 | $150 |
| Medical Device Business Services, Inc. | 3 | $123 |
| PFIZER INC. | 3 | $65 |
Products named: ERLEADA, RYBREVANT, Nubeqa, Xtandi, PROVENGE, ILLUCCIX, ZUSDURI, Moses.
Industry payments across NV — which companies pay providers there.
